Clinical trial suggests new direction for heavy-smoking head and neck cancer patients

Clinical trial suggests new direction for heavy-smoking head and neck cancer patients

IMAGE: David Raben, MD, and colleagues report promising phase 1 trial results of olaparib with cetuximab and radiation against heavy-smoker head and neck cancer. view more  Credit: University of Colorado Cancer Center Patients with a greater than 10 pack/year history of smoking tend to develop an especially dangerous form of head and neck squamous cell cancer […]

AIVITA Biomedical Announces Initiation of First Clinical Site for ROOT OF CANCER Glioblastoma Trial

AIVITA Biomedical Announces Initiation of First Clinical Site for ROOT OF CANCER Glioblastoma Trial

IRVINE, Calif., Aug. 14, 2018 /PRNewswire/ — AIVITA Biomedical, a biotech company specializing in innovative stem cell applications, announced today the initiation of its first clinical site for the Company’s ROOT OF CANCER Phase 2 trial in patients with newly diagnosed glioblastoma (GBM). The University of California, Irvine (UCI)’s Comprehensive Brain Tumor Program and the UCLA-UCI […]

Clinical Trials Have Far Too Little Racial and Ethnic Diversity

Clinical Trials Have Far Too Little Racial and Ethnic Diversity

Nearly 40 percent of Americans belong to a racial or ethnic minority, but the patients who participate in clinical trials for new drugs skew heavily white—in some cases, 80 to 90 percent. Yet nonwhite patients will ultimately take the drugs that come out of clinical studies, and that leads to a real problem. The symptoms […]

Sihuan Pharmaceutical's Self-Developed Innovative Oncology Drug Pirotinib Commenced Phase II Clinical Trial in China

Sihuan Pharmaceutical's Self-Developed Innovative Oncology Drug Pirotinib Commenced Phase II Clinical Trial in China

Led by Top Oncologist Professor Wu Yilong Expected to Commence Phase III Clinical Trial in 2H2019 Demonstrates Strong R&D Capability   Solidifies Oncology Drug Development Strategy HONG KONG, CHINA  – Media OutReach  – 13 August 2018 – Sihuan Pharmaceutical Holdings Group Ltd. (HKEx: 0460) (“Sihuan Pharmaceutical ” or the “Group “), the largest cardio-cerebral vascular (“CCV “) drug manufacturer in […]

Has Amyloid-Based Research Turned The Corner?

Has Amyloid-Based Research Turned The Corner?

FILE – This Oct. 7, 2003 file photo shows a section of a human brain with Alzheimer’s disease on display at the Museum of Neuroanatomy at the University at Buffalo, in Buffalo, N.Y. On Wednesday, July 25, 2018, two drug makers said an experimental therapy slowed mental decline by 30 percent in patients who got […]

Grant links Yale to prestigious stroke clinical trial network

Grant links Yale to prestigious stroke clinical trial network

Yale has received a grant to support the SPIRIT (Southern New England Partnership in Stroke Research, Innovation, and Treatment) Coordinating Center in StrokeNet. Partnering with Brown University and Hartford Healthcare, the consortium has become one of 29 National Institutes of Health (NIH) StrokeNet clinical trial sites, advancing stroke treatment, stroke prevention, and recovery and rehabilitation […]

American College of Rheumatology receives grant to help increase access to clinical trials

American College of Rheumatology receives grant to help increase access to clinical trials

ATLANTA, July 31, 2018 — The American College of Rheumatology (ACR) today announced the receipt of two, two-year grants from the Office of Minority Health (OMH) to support the development of programs that aim to increase the recruitment and enrollment in lupus clinical trials of minority populations affected by lupus. “This is the sixth year […]

India poised to become 'one of the largest clinical trial hubs,' says CRO

India poised to become 'one of the largest clinical trial hubs,' says CRO

George Clinical, a contract research organization (CRO) operating in the Asia-Pacific region, including India, said it welcomes the ongoing efforts of the Central Drugs Standard Control Organization (CSDCO​) of India to improve timelines and submission approval rates.  Vanaja Krishnan, managing director of George Clinical, India, said “ambiguity and uncertainty”​ surrounding regulatory procedures and “growing ethical […]